Abstract:KEYWORDS: The mitochondrial permeability transition (MPT) is defined as the loss of inner membrane a specific impermeability and transmembrane potential, due to the sustained opening of a large pore (the MPTP). The pore (also nicknamed Mitochondrial MegaChannel, MMC) has been characterized decades ago in studies with isolated mitochondria and – by our group – by single-channel patch-clamp on rat liver mitoplasts. Very similar activity (the Multi-Conductance Channel, MCC) was independently described by K.W. Kinnally's group (revs [ Citation 1 , Citation 2 ]). The awakening of this megachannel is elicited by increases in matrix Ca 2+ levels and is potentiated by other agents/processes, the major one being oxidative stress. The equivalent diameter of the pore can be as large as 3 nm but the channel exhibits a variety of sizes. In samples of isolated mitochondria, the molecular weight of permeating molecules increases as a function of the inducing Ca 2+ concentration and of the time elapsed since induction. Partial removal of the OMM would instead tend to decrease it [ Citation 3 ]. Prolonged opening is accompanied by depolarization, release of matrix components, further generation of reactive oxygen species (ROS), morphological changes (swelling, fragmentation of the mitochondrial network), decrease in cellular ATP levels, activation of mitophagy and, eventually, cell death. MPTP opening has been proposed to be involved in ischemia/reperfusion injury (IRI), aging and aging-associated neurodegenerative diseases, chronic stress syndrome, traumatic brain injury, muscular dystrophy, diabetes, cirrhosis, pancreatitis, osteoporosis, and more. In addition, cancer cells deploy desensitization mechanisms which help cancer growth and dispersion, and which may oppose chemotherapy. Inhibiting or activating the MPTP is therefore an exceptionally relevant pharmacological goal. As such, it has received much attention, but so far successes in pre-clinical models have not been accompanied by a proportionate impact in clinical practice. The effort continues. The MPTP is also believed to have physiological and protective roles under normal circumstances, by opening transiently to act as a 'Ca 2+ release valve,' preventing mitochondrial Ca 2+ overload, and tuning mitochondrial function [ Citation 4 , Citation 5 ]. This function appears to be particularly important in cardiac myocytes.

Why Don’t Equivalent Protons Split Each Other?

Mitochondrial Permeability Transition Dynamics: an Indicator of Mitochondrial Potassium Channel Opener.

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess

Deregulation of Mitochondrial Fusion and Fission in Neurodegenerative Diseases

Compartmental Differences in the Retinal Ganglion Cell Mitochondrial Proteome

The Proton Permeability of Self-Assembled Polymersomes and Their Neuroprotection by Enhancing a Neuroprotective Peptide Across the Blood-Brain Barrier after Modification with Lactoferrin.

Exploring mitochondrial targeting: an innovative fluorescent probe reveals Nernstian potential and partitioning combination

The mitochondria permeability transition pore complex in the brain with interacting proteins – promising targets for protection in neurodegenerative diseases

Mitochondrial Permeability Transition, Cell Death and Neurodegeneration

Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols

A Translocation Fluorescent Probe for Analyzing Cellular Physiology Parameters in Neurological Disease Models

Interactions and Transport of a Bioconjugated Peptide Targeting the Mitomembrane

Electrostatic Interaction-Mediated 1:1 Complexes for High-Contrast Mitochondrial-Targeted Phosphorescence Bioimaging

Rescuers from the Other Shore: Intercellular Mitochondrial Transfer and Its Implications in Central Nervous System Injury and Diseases

Mitochondrial permeability transition pore: a snapshot of a therapeutic target

Solute Transport through Mitochondrial Porins In Vitro and In Vivo

The Role of Mitochondria-Targeted Antioxidant MitoQ in Neurodegenerative Disease

Targeted Analysis of Mitochondrial Protein Conformations and Interactions by Endogenous ROS‐Triggered Cross‐Linker Release

Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1/M2 microglial polarization in an Alzheimer's disease model

Energy, Entropy and Quantum Tunneling of Protons and Electrons in Brain Mitochondria: Relation to Mitochondrial Impairment in Aging-Related Human Brain Diseases and Therapeutic Measures

The Dynamics Of The Mitochondrial Organelle As A Potential Therapeutic Target